R&D Transformation
& Lab Modernization

Scale science through connected, AI-ready lab infrastructure.

Modern R&D. Accelerated DMTA.

Research and development teams are reimagining the lab as a connected, automated, AI-driven, cloud-enabled ecosystem — one where data flows seamlessly from instruments to analytics, and where automation removes friction from everyday scientific work. We help bring that vision to life through modernized lab platforms and integrations, strengthened data foundations and governance, and the application of intelligent automation.

The result is a Lab of the Future model that scales science through connectivity, traceability, and workflow-ready transformation — so teams can move from insight to impact with speed and confidence. We bring this new model to life through a unique combination of deep scientific domain expertise, physical and digital engineering capabilities, and AI-native delivery.

Our Core Capabilities

WHITE PAPER

LotF: Four Strategic Priorities for Near-Term Transformation

CASE STUDY

Supporting Genosity’s End-to-End Lab Processes

BLOG

Optimize Before You Automate: Process Excellence in the Lab

CASE STUDY

Scaling Data Analytics & Decision-Making for Syngenta

Addressing What Matters Most

Making every data point count toward discovery

Most labs generate far more data than they can use — siloed outputs, inconsistent formats and non-FAIR architecture all block AI readiness and cross-functional collaboration. We help organizations build the data foundations that turn raw instrument output into a strategic asset: accessible, governed and ready to power discovery.

Compressing the distance from insight to action

Every gap between analysis and the next design decision costs time, budget and competitive position. We close that gap by connecting DMTA workflows end-to-end, so data flows automatically into the next experiment, cycles shorten and the value of every run compounds forward.

Building the vision before choosing the tools

The market offers no shortage of platforms, vendors and AI capabilities. But technology without strategy digitizes broken workflows. We start with lab vision, data modeling and process design — every platform and automation investment is made in the right order, for the right reasons.

Treating compliance as a foundation, not a constraint

GxP, 21 CFR Part 11, Annex 11, ALCOA+ — the regulatory surface area for digital lab systems keeps growing. We design with compliance in mind, so validation, data integrity and audit readiness accelerate transformation rather than slow it down.

Making every data point count toward discovery

Compressing the distance from insight to action

Building the vision before choosing the tools

Treating compliance as a foundation, not a constraint

How We Work with You

We connect strategy, execution, data, AI, cloud and compliance into a single interoperable pipeline — giving organizations the comprehensive digital backbone they need to help You scale compliant innovation from discovery through development.

Advisory

Strategic Advisory & Lab Vision
Informatics & Technology Assessment
Data Governance & Modeling
Organizational Change & Enablement

Wet Lab: Implementation

LIMS / ELN Implementation
Smart Labs: Lab Connectivity & IoT
Platform Configuration
System Integration

Dry Lab: Data & AI

Data Foundations for AI (FAIR Architecture)
Bioinformatics Pipelines
AI-Accelerated Discovery & DMTA

Compliance

Accessibility to information (GxP – GLP, GMP, GCP, 21 CFR Part 11 / Annex 11, Validation Packages – IQ/OQ/PQ, Data Integrity – ALCOA+), that can assist your legal advisor as they independently assess your organization’s legal compliance.*

*The content provided on this offering webpage is for informational purposes only. EPAM is not a law firm or medical practice and does not provide any legal, medical or other regulatory advice or services. EPAM is not be responsible for Customer’s legal and/or regulatory compliance and should not be relied upon for such compliance. Customer is solely responsible for determining whether the Solution is sufficient to allow Customer to comply with any laws. EPAM is not a medical device manufacturer and the Solution does not constitute a medical device. The Customer remains responsible for its use of the Solution and any decisions Customer makes based on the inherent elements of the Solution.

FEATURED

EPAM CORA™ for AWS HealthOmics

Designed for biomedical R&D labs, bench scientists and clinical providers, CORA™ supports population sequencing, high-throughput bioinformatics and collaborative workflow development — all in a user-friendly, extensible environment.